Michael J. Valentino, President & CEO at Adams Respiratory Therapeutics, Inc. (ARXT), sold 23,399 shares at $35.51 ($830K) on 2006-10-02, disclosed to the SEC on 2006-10-04.
Scheduled sale ($830k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.28 | 100 | $4K | 0.4% |
| 2 | $35.30 | 100 | $4K | 0.4% |
| 3 | $35.31 | 100 | $4K | 0.4% |
| 4 | $35.32 | 100 | $4K | 0.4% |
| 5 | $35.33 | 200 | $7K | 0.9% |
| 6 | $35.35 | 1,075 |
| $38K |
| 4.6% |
| 7 | $35.39 | 300 | $11K | 1.3% |
| 8 | $35.40 | 800 | $28K | 3.4% |
| 9 | $35.41 | 1,100 | $39K | 4.7% |
| 10 | $35.42 | 529 | $19K | 2.3% |
| 11 | $35.43 | 1,696 | $60K | 7.2% |
| 12 | $35.44 | 663 | $23K | 2.8% |
| 13 | $35.45 | 2,100 | $74K | 9.0% |
| 14 | $35.46 | 300 | $11K | 1.3% |
| 15 | $35.47 | 1,100 | $39K | 4.7% |
| 16 | $35.48 | 2,300 | $82K | 9.8% |
| 17 | $35.49 | 892 | $32K | 3.8% |
| 18 | $35.50 | 900 | $32K | 3.8% |
| 19 | $35.51 | 3,300 | $117K | 14.1% |
| 20 | $35.52 | 961 | $34K | 4.1% |
| 21 | $35.53 | 552 | $20K | 2.4% |
| 22 | $35.54 | 600 | $21K | 2.6% |
| 23 | $35.55 | 300 | $11K | 1.3% |
| 24 | $35.56 | 500 | $18K | 2.1% |
| 25 | $35.57 | 300 | $11K | 1.3% |
| 26 | $35.58 | 431 | $15K | 1.8% |
| 27 | $35.59 | 1,400 | $50K | 6.0% |
| 28 | $35.60 | 200 | $7K | 0.9% |
| 29 | $35.61 | 500 | $18K | 2.1% |
| Total | $35.48 avg | 23,399 | $830K | 100% |
| Filing → |
| PLXP | BUY | 2020-11-20 | $1.0M | — | Filing → |
| PLXP | BUY | 2019-05-21 | $497K | — | Filing → |
| PLXP | BUY | 2017-06-16 | $400K | — | Filing → |